This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Zimmermann, M. B. Articles by Torresani, T. Search for Related Content PubMed PubMed Citation Articles by Zimmermann, M. B. Articles by Torresani, T.

The Effects of Vitamin A Deficiency and Vitamin A Supplementation on Thyroid Function in Goitrous Children

Human Nutrition Laboratory, Swiss Federal Institute of Technology Zurich (M.B.Z., R.W., C.Z.), CH-8803 Ruschlikon, Switzerland; Ministry of Health (N.C.), Rabat, Agdal-10000 Morocco; and Department of Endocrinology, University Children’s Hospital (T.T.), CH-8032 Zurich, Switzerland

Address all correspondence and requests for reprints to: Dr. M. Zimmermann, Human Nutrition Laboratory, Swiss Federal Institute of Technology Zurich, Seestrasse 72/Postfach 474, CH-8803 Ruschlikon, Switzerland. E-mail: michael.zimmermann{at}ilw.agrl.ethz.ch.

In developing countries, children are at high risk for both the iodine deficiency disorders (IDD) and vitamin A deficiency (VAD). The study aim was to determine the effects of VAD and vitamin A (VA) supplementation on thyroid function in an area of endemic goiter. In a double-blind, randomized, 10-month trial, Moroccan children with IDD and VAD (n = 138) were given iodized salt and either VA (200,000 IU) or placebo at 0 and 5 months. At 0, 5, and 10 months, measurements of VA status and thyroid function were made. At baseline, increasing VAD severity was a predictor of greater thyroid volume and higher concentrations of TSH and thyroglobulin (P < 0.001). In children with VAD, the odds ratio for goiter was 6.51 (95% confidence interval, 2.94, 14.41). VAD severity was also a strong predictor of higher concentrations of total T₄ (P < 0.001); the odds ratio for hypothyroidism in VAD was 0.06 (95% confidence interval, 0.03, 0.14). During the intervention, mean thyroglobulin, median TSH, and the goiter rate significantly decreased in the VA-treated group compared with those in the placebo group (P < 0.01). The findings indicate that VAD in severely IDD-affected children increases TSH stimulation and thyroid size and reduces the risk for hypothyroidism. This effect could be due to decreased VA-mediated suppression of the pituitary TSHß gene. In IDD- and VAD-affected children receiving iodized salt, concurrent VA supplementation improves iodine efficacy.

This article has been cited by other articles:

				M. B. Zimmermann Iodine Deficiency Endocr. Rev., June 1, 2009; 30(4): 376 - 408. [Abstract] [Full Text] [PDF]

				M. B Zimmermann, P. L Jooste, N. S. Mabapa, S. Schoeman, R. Biebinger, L. F Mushaphi, and X. Mbhenyane Vitamin A supplementation in iodine-deficient African children decreases thyrotropin stimulation of the thyroid and reduces the goiter rate Am. J. Clinical Nutrition, October 1, 2007; 86(4): 1040 - 1044. [Abstract] [Full Text] [PDF]

				R. Biebinger, M. Arnold, W. Langhans, R. F. Hurrell, and M. B. Zimmermann Vitamin A Repletion in Rats with Concurrent Vitamin A and Iodine Deficiency Affects Pituitary TSH{beta} Gene Expression and Reduces Thyroid Hyperstimulation and Thyroid Size J. Nutr., March 1, 2007; 137(3): 573 - 577. [Abstract] [Full Text] [PDF]